131.
Mullen W, Gonzalez J, Siwy J, Franke J, Sattar N, Mullan A, Roberts S, Delles C, Mischak H, Albalat A.
A Pilot Study on the Effect of Short-Term Consumption of a Polyphenol Rich Drink on Biomarkers of Coronary Artery Disease Defined by Urinary Proteomics
J Agric Food Chem. 2011, 59(24):12850-7
View
Abstract Request
Reprint
130.
Jahn H, Wittke S, Zürbig P, Raedler TJ, Arlt S, Kellmann M, Mullen W, Eichenlaub M, Mischak H, Wiedemann K
Peptide fingerprinting of Alzheimer´s disease in cerebrospinal fluid: Identification and prospective evaluation of new synaptic biomarkers
PLoS ONE 2011, 6(10): e26540
View
Abstract Request
Reprint
129.
Albalat A, Mischak H, Mullen W.
Clinical application of urinary proteomics/peptidomics
Expert Rev Proteomics 2011, 8(5):615-29.
View
Abstract Request
Reprint
128.
Mullen W, Delles C, Mischak H; members of EuroKUP COST action.
Urinary proteomics in the assessment of chronic kidney disease
Curr Opin Nephrol Hypertens. 2011, 20(6):654-61.
View
Abstract Request
Reprint
127.
Mischak H, Thongboonkerd V, Schanstra JP, Vlahou A
Renal and urinary proteomics
Proteomics Clin Appl. 2011, 5(5-6):211-3.
View
Abstract Request
Reprint
126.
Albalat A, Mischak H, Mullen W
Urine proteomics in clinical applications: technologies, principal considerations and clinical implementation
Prilozi. 2011, 32(1):13-44.
View
Abstract Request
Reprint
125.
Kistler AD, Siwy J, Breunig F, Jeevaratnam P, Scherl A, Mullen W, Warnock DG, Wanner C, Hughes DA, Mischak H, Wüthrich RP, Serra AL
A distinct urinary biomarker pattern characteristic of female Fabry patients that mirrors response to Enzyme Replacement Therapy
PLoS One. 2011, 6(6):e20534. Epub 2011 Jun 15.
View
Abstract Request
Reprint
124.
Zürbig P, Dihazi H, Metzger J, Thongboonkerd V, Vlahou A
Urine proteomics in kidney and urogenital diseases: Moving towards clinical applications
Proteomics Clin Appl. 2011, 5(5-6):256-68.
123.
Siwy J, Mullen W, Golovko I, Franke J, Zürbig P
Human urinary peptide database for multiple disease biomarker discovery
Proteomics Clin Appl. 2011, 5(5-6):367-74.
View
Abstract Request
Reprint
122.
Metzger J, Chatzikyrkou C, Broecker V, Schiffer E, Jaensch L, Iphoefer A, Mengel M, Mullen W, Mischak H, Haller H, Gwinner W
Diagnosis of subclinical and clinical acute T-cell-mediated rejection in renal transplant patients by urinary proteome analysis
Proteomics Clin Appl. 2011, 5(5-6):322-33.
View
Abstract Request
Reprint
121.
Schiffer E, Liabeuf S, Lacroix C, Temmar M, Renard C, Monsarrat B, Choukroun G, Lemke HD, Vanholder R, Mischak H, Massy ZA; on behalf of the European Uremic Toxin Work Group (EUTox).
Markers of vascular disease in plasma from patients with chronic kidney disease identified by proteomic analysis
J Hypertens. 2011, 29(4):783-790.
View
Abstract Request
Reprint
120.
Carty DM, Siwy J, Brennand JE, Zürbig P, Mullen W, Franke J, McCulloch JW, North RA, Chappell LC, Mischak H, Poston L, Dominiczak AF, Delles C.
Urinary Proteomics for Prediction of Preeclampsia
Hypertension. 2011, 57(3):561-9.
View
Abstract Request
Reprint
119.
Ehrich JH, Schiffer E, Drube J.
Urinary proteomics : The diagnostic key for urinary tract abnormalities and kidney diseases in children?
Urologe A. 2011, 50(2):170-179.
View
Abstract Request
Reprint
118.
Mayer G, Heinze G, Mischak H, Hellemons ME, Heerspink HJ, Bakker SJ, de Zeeuw D, Haiduk M, Rossing P, Oberbauer R
Omics-bioinformatics in the context of clinical data
Methods Mol Biol. 2011, 719:479-97.
View
Abstract Request
Reprint
117.
Mischak H, Schanstra JP.
CE-MS in biomarker discovery, validation, and clinical application
Proteomics Clin Appl. 2011, 5(1-2):9-23.
View
Abstract Request
Reprint
116.
Schiffer E
Urinary proteomics: ready for prime time in urological cancer diagnostics?
Personalized Medicine 2011, Jan;8 (1): 81-94.
View
Abstract Request
Reprint
115.
Siwy J, Vlahou A, Zimmerli LU, Zürbig P, Schiffer E
Clinical proteomics: Current techniques and potential applications in the elderly
Maturitas. 2011, 68(3):233-44
View
Abstract Request
Reprint
114.
Foucher C, Schiffer E, Mischak H, Ansquer JC, Wilbraham D
Effect of fenofibrate treatment on the low molecular weight urinary proteome of healthy volunteers
Proteomics Clin Appl. 2011, 5(3-4):159-66.
View
Abstract Request
Reprint
113.
Lankisch TO, Metzger J, Negm AA, Voßkuhl K, Schiffer E, Siwy J, Weismüller TJ, Andrea S. Schneider AS, Thedieck K, Baumeister R, Zuerbig P, Weissinger EM, Manns MP, Mischak H, Wedemeyer J
Bile proteomic profiles differentiates cholangiocarcinoma from primary sclerosing cholangitis and choledocholithiasis
Hepatology. 2011, 53(3):875-884.
View
Abstract Request
Reprint
Rotenburger Str. 20
D-30659 Hannover
Germany
Phone: +49 (0)511 55 47 44 0
Fax: +49 (0)511 55 47 44 31
Copyright © 2024 Imprint